These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8485428)

  • 1. Patterns of drug use and risk-taking among injecting amphetamine and opioid drug users in Sydney, Australia.
    Hall W; Darke S; Ross M; Wodak A
    Addiction; 1993 Apr; 88(4):509-16. PubMed ID: 8485428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug use and HIV risk-taking behaviour among injecting drug users not currently in treatment in Sydney, Australia.
    Baker A; Kochan N; Dixon J; Wodak A; Heather N
    Drug Alcohol Depend; 1994 Jan; 34(2):155-60. PubMed ID: 8026303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV risk-taking behaviour among amphetamine users in Sydney, Australia.
    Hando J; Hall W
    Addiction; 1994 Jan; 89(1):79-85. PubMed ID: 8148747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injecting and sexual risk-taking behaviour among regular amphetamine users.
    Darke S; Ross J; Cohen J; Hando J; Hall W
    AIDS Care; 1995; 7(1):19-26. PubMed ID: 7748906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of benzodiazepines among regular amphetamine users.
    Darke S; Ross J; Cohen J
    Addiction; 1994 Dec; 89(12):1683-90. PubMed ID: 7866252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis.
    Tavitian-Exley I; Boily MC; Heimer R; Uusküla A; Levina O; Maheu-Giroux M
    AIDS Behav; 2018 Apr; 22(4):1329-1340. PubMed ID: 28699018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.
    Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C
    Addiction; 1996 Oct; 91(10):1457-67. PubMed ID: 8917914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing popularity of injection as the route of administration of amphetamine in Edinburgh.
    Peters A; Davies T; Richardson A
    Drug Alcohol Depend; 1997 Dec; 48(3):227-34. PubMed ID: 9449022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.
    Des Jarlais DC; Arasteh K; Perlis T; Hagan H; Abdul-Quader A; Heckathorn DD; McKnight C; Bramson H; Nemeth C; Torian LV; Friedman SR
    AIDS; 2007 Jan; 21(2):231-5. PubMed ID: 17197815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-related risk-taking behaviour, knowledge and serostatus of intravenous drug users in Sydney.
    Wolk J; Wodak A; Morlet A; Guinan JJ; Gold J
    Med J Aust; 1990 May; 152(9):453-8. PubMed ID: 2381335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transitions between the injection of heroin and amphetamines.
    Darke S; Kaye S; Ross J
    Addiction; 1999 Dec; 94(12):1795-803. PubMed ID: 10717958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic.
    Uusküla A; Raag M; Marsh K; Talu A; Vorobjov S; Des Jarlais D
    PLoS One; 2017; 12(2):e0170956. PubMed ID: 28152026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and Russia.
    Tavitian-Exley I; Maheu-Giroux M; Platt L; Heimer R; Uusküla A; Levina O; Vickerman P; Boily MC
    Int J Drug Policy; 2018 Mar; 53():96-105. PubMed ID: 29306786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition to injection amongst opioid users in Iran: implications for harm reduction.
    Malekinejad M; Vazirian M
    Int J Drug Policy; 2012 Jul; 23(4):333-7. PubMed ID: 21996166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the harms associated with the injection of heroin and amphetamines.
    Kaye S; Darke S
    Drug Alcohol Depend; 2000 Feb; 58(1-2):189-95. PubMed ID: 10669071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
    Talu A; Rajaleid K; Abel-Ollo K; Rüütel K; Rahu M; Rhodes T; Platt L; Bobrova N; Uusküla A
    Int J Drug Policy; 2010 Jan; 21(1):56-63. PubMed ID: 19395249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug use, injecting practices and sexual behaviour of opioid users in Sydney, Australia.
    Darke S; Hall W; Carless J
    Br J Addict; 1990 Dec; 85(12):1603-9. PubMed ID: 2289060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The injection of methadone syrup in New South Wales: patterns of use and increased harm after partial banning of injecting equipment.
    Hopwood M; Southgate E; Kippax S; Bammer G; Isaac-Toua G; MacDonald M
    Aust N Z J Public Health; 2003 Oct; 27(5):551-5. PubMed ID: 14651404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
    Day C; Conroy E; Lowe J; Page J; Dolan K
    Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.